Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up
Clinical trial NCT02549339 · COMPLETED
Trial details
- NCT number
- NCT02549339
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-13
- Primary completion
- 2016-08-05
- Enrollment
- 383
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.